Skip to main content

Novel Strategies of Regenerative Medicine Using Chemical Compounds

Buy Article:

$55.00 plus tax (Refund Policy)

Many diseases and/or physical defects due to injury result in the loss of specialized cells within organ systems and lead to organ system dysfunction. The ultimate goal of cell-based therapies is to regenerate and restore normal function. Populations of embryonic, fetal, adult stem cells and inducible pluripotent stem cells generated by reprogramming of adult cells show promise for the treatment of a variety of diseases. In addition, the recent advancements in adult stem cell biology in both normal and pathological conditions have led to the identification of some intrinsic and extrinsic factors that govern the decision between self renewal versus differentiation of tissue-resident adult stem cells. This is of primary importance for the design of an approach of stem cell-based therapy focused on their in vivo modulation by conventional chemical and biological therapeutics capable to stimulate endogenous cell regeneration. Such therapeutics can act in vivo to promote cell survival, proliferation, differentiation, reprogramming and homing of stem cells or can modulate their niches. In this review, we will highlight the burst of recent literature on novel perspectives of regenerative medicine and their possible clinical applications.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: APC; Alzheimer's disease; Angelotti; Ballerini; BayK8644; BrdUlabeled; Conophylline; Crosstalk Among Wnt; Cyclopamine; DAPT; DAPT treatment; ERK Signal Transduction Pathways; Frizzled activates; GDC-0449; Hedgehog (Hh); Hedgehog Signal Transduction Pathway; Hh; MEK inhibitor; Notch; Notch transmembrane; OSKM; P. Romagnani; Purmorphamine; Ras; Regenerative Medicine; Runx2 expression; SAHA; SOMATIC CELLS; Sagrinati; Smoothened; Stem cell; TRANSDUCTION PATHWAYS; Wnt; a cardiovascular; adenomatous polyposis coli (APC) complex; adipogenic; adult subventricular zone; cardiomyocytes; clonogenicity; deoxojervine; dibenzazepine; downregulation of MEF-specific genes; endogenous regeneration; epidermal; generate teratomas; genetic aberrations; glucagon; hemodynamic overload; iPS cells; iPSC; iPSC generation; megakariocyte recovery; metalloproteinases; microenvironment; molecule guanosine triphosphate (GTP); myelogenous leukemia; neocortical development; neuronal progenitors; osteogenic; oxovanadium(IV); pluripotent state; proliferating myoblasts; proliferating progeny; proliferation; proliferator-activated; proteolytic degradation; ubiquitination; undergo cardiomyogenic

Document Type: Research Article

Publication date: 2010-12-01

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more